Therapeutic problems in patients with congenital adrenal hyperplasia from 11-β-hydroxylase deficiency
More details
Hide details
Students’ Scientific Club at the Department of Pathophysiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
Department of Pathophysiology, Faculty of Medical Sciences in Zabrze, Medical University of Silesia, Katowice, Poland
Corresponding author
Anita Ptak   

Studenckie Koło Naukowe przy Zakładzie Patofizjologii Katedry Patofizjologii i Endokrynologii, Wydział Nauk Medycznych w Zabrzu, Śląski Uniwersytet Medyczny w Katowicach, ul. Jordana 19, 41-808 Zabrze
Ann. Acad. Med. Siles. 2024;78:113-117
Congenital adrenal hyperplasia (CAH) with 11-β-hydroxylase deficiency accounts for a small percentage of the overall incidence of this disease in the population. The described case of two sisters touches on the therapeutic problems encountered during the treatment of this rare condition. The authors present the problem of selecting appropriate substitutive doses of glucocorticosteroids that will ensure good control of blood pressure and protect against the development of organ complications caused by hypertension and maintain hirsutism at an acceptable level, with as few complications of the applied treatment as possible. The article emphasizes the role of patient–physician cooperation, which is essential to achieve the therapeutic goals.
Papierska L. Wrodzony przerost nadnerczy. In: M. Otto [ed.]. Diagnostyka i leczenie chorób nadnerczy. Wyd. Lekarskie PZWL. Warszawa 2013, p. 126–132.
Starzyk J. Wrodzony przerost nadnerczy. In: W. Kawalec, R. Grenda, M. Kulus [ed.]. Pediatria 2. 2nd ed. Wyd. Lekarskie PZWL. Warszawa 2018, p. 1009–1012.
Sun B., Lu L., Gao Y., Yu B., Chen S., Tong A. et al. High prevalence of hypertension and target organ damage in patients with 11β-hydroxylase deficiency. Clin. Endocrinol. (Oxf.) 2022; 96(5): 657–665, doi: 10.1111/cen.14677.
Williams B., Mancia G., Spiering W., Rosei E.A., Azizi M., Burnier M. et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. [Article in Polish]. Kardiol. Pol. 2019; 77(2): 71–159, doi: 10.5603/KP.2019.0018.
Januszewicz A., Prejbisz A., Dobrowolski P., Stompór T., Kosiński P., Sułowicz W. Nadciśnienie tętnicze. In: P. Gajewski [ed.]. Interna Szczeklika 2021. Wyd. Medycyna Praktyczna. Kraków 2022, p. 459–484.
Journals System - logo
Scroll to top